A detailed history of Al Ti Global, Inc. transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Al Ti Global, Inc. holds 200,288 shares of GNTA stock, worth $1.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200,288
Holding current value
$1.02 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.55 - $3.95 $510,734 - $791,137
200,288 New
200,288 $621 Million

Others Institutions Holding GNTA

About Genenta Science S.p.A.


  • Ticker GNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,216,900
  • Market Cap $92.9M
  • Description
  • Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...
More about GNTA
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.